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ABSTRACT 
“A prospective randomised study comparing different approaches to 
intraoperative management of diabetes mellitus – The Vellore Regimen vs 
Intermittent IV Bolus Regimen” 
Background: 
Diabetes mellitus is a common metabolic disorder with relevant 
anaesthetic implications. The large number of trials aiming to arrive at an ideal 
protocol  for intraoperative management of the disease have so far not lead to a 
widely accepted and agreeable solution. This might be due, in part, to poor 
adherence because of inconvenient strategies. 
In this study, I aim to conclude whether the simple and easy intermittent 
intravenous insulin bolus regimen can stand up to the mostly followed Vellore 
regimen in efficiency and safety. 
Method: 
This was a unicentric randomised prospective trial in vascular surgery 
patients who have type 2 diabetes mellitus. 70 patients were chosen based on 
predefined criteria and randomly divided into 2 groups .Patients from each 
group were subjected to hourly intraoperative monitoring and insulin dosing 
depending on the group .Statistical approach- Primary outcome measures- The 
mean with standard deviation of glycaemic readings of each hour were 
calculated within each group and then compared across the groups for statistical 
significance .Secondary outcome measures -The difference in the percentage of 
people with uncontrolled sugars (defined as blood glucose values outside 100 -
200 mg %) between hour 0 and hour 3 was calculated and compared across both 
the groups. Tertiary outcome measure-The approach used for primary outcome 
measure was applied only to patients with poor pre operative glycaemic control. 
Results: 
The groups were well balanced for baseline characteristics except for the 
slightly higher mean PPBS in the intermittent iv bolus group. Since the FBS in 
both groups was comparable, the confounding factor of preoperative blood 
glucose control can be taken as insignificant in this case. It was seen that  the 
decreased mean blood glucose measurement in Vellore Regimen Group 
compared to the Insulin Bolus Regimen Group is statistically significant as the p 
value is 0.0367 at 2 hours and 0.0383 at 3 hours intraoperatively as per unpaired 
t- test indicating a true difference among study groups.For the secondary 
outcome , in comparing the difference between the number of patients who 
were outside the target range at hour 0 and hour 3 between both the groups 
every hour , we find that for the Vellore regimen , the percentage dropped from 
63% to 0% , while for the insulin bolus regimen it decreased from  17 % to 5 % 
. Although the Vellore Regimen takes the upper hand here, the finding was not 
found to be statistically significant .Coming to the tertiary outcome, In patients 
belonging to Insulin Bolus Regimen Group, the mean Blood Glucose 
Monitoring  of Patients who had Poor Control at Assessment ( FBS≥126, 
PPBS≥200) ranged from 211 mg/dl at baseline to 160.60 mg/dl at the end of  
hour 3.  The comparison turned out to be insignificant although it was in favour 
of the Vellore regimen 
Conclusion: 
Based on the above findings, I conclude that the Vellore regimen is 
marginally more efficacious as well as safer than the intermittent intravenous 
insulin bolus regimen. 
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INTRODUCTION 
“A PROSPECTIVE RANDOMISED STUDY COMPARING 
DIFFERENT APPROACHES TO INTRAOPERATIVE 
MANAGEMENT OF DIABETESMELLITUS – THE VELLORE 
REGIMEN VS INTERMITTENT IV BOLUS REGIMEN” 
Multiple protocols have been developed for perioperative glucose 
control, ranging from intravenous glucose – insulin – potassium infusion 
regimens to subcutaneous sliding scale insulin bolus regimens. Despite 
the multitude of results and conclusions, there is no real evidence of an 
optimal protocol. 
The aim of this study is to make a comparison between 2 different 
approaches of administering insulin intraoperatively namely, a continuous 
insulin infusion regimen with an intravenous insulin bolus regimen. The 
aim is, by means of judging the efficiency of blood sugar control between 
the 2 groups, to determine whether the naturally more convenient IV 
bolus regimen compares favourably to the more accepted continuous 
infusion regimen. The Vellore regimen was chosen as the prototype of the 
infusion regimens. 
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AIM  
To compare the effectiveness of intra operative control of blood 
glucose of The Vellore Regimen vs Intermittent IV Bolus Regimen 
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BACKGROUND 
Diabetes mellitus has gained much prominence in the present age, 
not least due to modern lifestyle. This metabolic disorder affecting 
multiple systems is of great importance to physicians and is a significant 
risk factor for some of the major causes of death like heart attack and 
stroke. The silent disease, with an initial non dramatic course of events is 
even more notorious for the wide range of morbidities it inflicts upon it’s 
sufferers. Causing entities such as diabetic retinopathy, diabetic 
nephropathy, peripheral neuropathy, diabetic foot and increased 
susceptibility to a host of infections, it affects almost every organ from 
head to toe. Anaesthesiologists, being perioperative physicians, should be 
equally concerned of it’s effects as it has a bearing upon case 
optimization, management and post operative recovery.  
To offer a brief synopsis of the pathophysiology, the disease is a 
common endocrinopathy. The normal metabolism of glucose involves a 
balance between the use of glucose and it’s production within the body or 
delivery by diet. The primary source of endogenous glucose production is 
the liver. This happens by means of glycogenolysis and gluconeogenesis. 
The postprandial surge in blood glucose levels stimulates a rise in plasma 
insulin secretion from the basal level,in order to effect utilisation of 
glucose.  
 4 
About 2-4 hours after a meal, glucose utilisation surpasses 
endogenous production and hence it becomes necessary to increase the 
endogenous production to maintain normal levels of blood glucose. 
During this period, a great proportion of glucose released hepatically is 
metabolised by insulin independent tissues like the brain, RBCs and GIT, 
which are not sensitive to insulin and hence the insulin secretion is at a 
low. 
Hormones like glucagon, epinephrine, growth hormone and 
cortisol act to increase the blood glucose levels and support production. 
The primary one of these is glucagon which stimulates glycogenolysis 
and gluconeogenesis and inhibits glycolysis. 
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Diabetes mellitus is the result of either or both of 
1. Reduced insulin supply 
2. Insulin resistance 
The result is a high blood sugar level which ultimately causes the 
numerous complications we have come to expect from the disease. 
Diabetes mellitus occurs in 2 major forms  
1. Type 1 diabetes, a disease involving destruction of beta cells in the 
pancreas, which is brought about by T cells. The disease is mostly 
diagnosed in young adults before the age of 40 years. The exact 
aetiology is not well known and a variety of factors are implicated 
in causing the disease –environmental triggers eg. Enteroviruses, 
dietary proteins, or drugs or chemicals that may set the 
pathological processes in motion in genetically susceptible 
individuals. About, 80-90 % of beta cell function is lost over a 
preclinical period of 9 – 12 years before symptoms set in. A 
marker of the disease is the circulating antibodies. It is 
distinguished by sudden and severe presentation with 
hyperglycaemia, weight loss, polyuria, polydipsia, blurring of 
vision and dehydration. 
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2. Type 2 diabetes, the most common variant accounting for 90 % of 
the worldwide occurrence of DM. The subtle disease tends to 
happen more in overweight people living a sedentary lifestyle. It is 
characterised by relative insufficiency of beta cells and resistance 
to insulin. The initial insensitivity to insulin in tissues leads to an 
increase in insulin secretion by the pancreas, to keep normal 
plasma glucose levels. As the disease moves on cells of the 
pancreas get exhausted and are not able to compensate, due to 
which the blood glucose levels rise. The situation is characterised 
by 3 important aspects 
A. inefficient use of glucose by peripheral tissues. 
B. impaired basal and stimulated insulin secretion.  
C. increase in the rate of hepatic glucose release.  
Insulin resistance is attributed to many factors like abnormal 
insulin molecule, free fatty acids, circulating insulin antagonists, anti 
insulin and insulin receptor antibodies, cytokines, target tissue defects. It 
is also thought that the resistance may be an inherited component, while 
obesity and sedentary lifestyle are acquired ones. Metabolic syndrome, 
also called insulin resistance syndrome, is a group of biochemical and 
clinical features mostly seen in patients who suffer from or are likely to 
develop type 2 diabetes mellitus. It includes insulin resistance, 
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hypertension, obesity, procoagulant state, dyslipidaemia, premature 
atherosclerosis and cardiovascular disease.  
Diagnosis  
According to the standards of medical care in diabetes 2015, by 
The American Diabetes Association the revised diagnostic criteria are as 
follows 
Glycosylated Hb≥.5%. 
Or 
Fasting plasma glucose≥126 mg/dl. Fasting is characterised by lack of 
caloric intake for at least 8 hours. * 
Or 
Post prandial plasma glucose≥200 mg/dl during an oral glucose tolerance 
test. The test must be done as described by the WHO, using a load of 
glucose containing the equivalent of 75 g anhydrous glucose dissolved in 
water.* 
Or 
A patient who has classic symptoms of raised blood sugars or 
hyperglycaemic crisis with a random plasma glucose ≥200 mg/dl.  
*if in doubt the tests should be repeated 
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Perioperative blood glucose control in diabetic patients 
Diabetes mellitus, being a disorder that affects multiple systems, 
requires the anaesthesiologist to conduct a thorough pre operative 
evaluation for complications, control, therapy and airway assessment. 
The management strategy differs,accordingly.  
In addition, it is imperative to keep blood glucose values in a 
certain range so that we can prevent disastrous add- on complications 
including poor surgical outcome. A situation of insulin hypo secretion 
(which should be seen as relative ) and resistance to insulin can be caused 
by anaesthesia as well as surgery, due to release of hormones which act to 
oppose insulin. The counter regulatory hormones are glucocorticoids, 
growth hormone, glucagon and catecholamines. The degree of 
counterregulatory activity varies with individuals. It is associated with 
various surgical factors as well as the outcome after surgery. The 
hyperglycaemia associated with surgery is proportional to the stress, 
duration and type of surgery2. The hyperglycaemic response to these 
factors may be attenuated by the lack of caloric intake during and 
immediately after surgery, making the final glycaemic balance difficult to 
predict. The degree of rise of blood sugar may be reduced by not having 
intake of calories perioperatively, which, however makes the balance of 
blood sugar difficult to foresee.  
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Raised sugars during surgery can cause dangerous states of 
dehydration like diabetic ketoacidosis and hyperosmolar hyperglycaemia 
which can be lethal. Type 2 diabetic patients are specially prone to the 
latter. Electrolyte abnormalities are quick to occur in the above discussed 
problems, bringing their own set of complications to the scene. 
Persistently high blood sugars are also attributed to impaired wound 
healing, endothelial dysfunction, sepsis and cerebral ischaemia.  
Blood glucose levels are also often likely to plummet, especially in 
cases with poor pre operative control, long fasting duration and receiving 
of immediate pre op doses of insulin or oral hypoglycaemic agent. A 
reduced blood glucose of say less than 40 – 50 mg% for a few minutes 
can cause damage in the form of arrhythmias or problems with higher 
functions. A more prolonged insult may result in hypoglycaemic coma 
due to irreversible brain damage. Hypoglycaemia and subsequent neuro-
glucopaenia are hard to make out in sleeping patients, after surgery. 
The target intra operative levels of blood glucose is a matter of 
ongoing studies and discussions. From what we know, tight control of 
sugar i.e. Levels between 108 mg% - 144 mg% are suggested for major 
surgeries like vascular surgeries, cardiac surgeries and neurological 
surgeries, though these often result in hypoglycaemia. There are studies 
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which do not advocate the above approach. General surgeries mostly see 
an approach of moderate control i.e 140 mg% - 180mg%.  
Patients with controlled blood glucose levels through diet and 
exercise 
For these patients, if undergoing minor surgery, no special 
treatment is recommended except for early morning monitoring and 
intraoperative monitoring of blood glucose if the duration of the 
procedure exceeds an hour. If the procedure is a major one, then an active 
intervention is needed.  
Patients on oral hypoglycaemic drugs 
A major surgery, where the patient is not going to resume eating 
soon after surgery, requires a changeover to insulin 2 days prior. If the 
surgery is a minor one no such shift is needed. Long acting sulfonylureas 
are withheld 1 day prior. Chlorpropamide should be stopped2-3 days 
prior to surgery. Metformin, 48-72 hours prior. It can be restarted after 
48-72 hours of surgery once renal function tests have been shown to be 
normal. Short acting oral hypoglycaemic drugs can be continued up to the 
day of surgery. Some advice skipping the morning dose.  
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Patients on insulin therapy 
For minor surgery, patients on long acting insulin should be 
changed to insulin which acts for an intermediate duration 24 – 48 hours 
prior to surgery11. Checking blood sugar around the surgical period is 
very much necessary and a glucose insulin infusion is best started before 
the surgery itself. Post operatively, the infusion must be halted11 and the 
regularly followed subcutaneous regimen should be followed once the 
patient commences eating. Intraoperative control is of course with 
intravenous insulin and glucose.  
In case of major surgery, the patient is to be admitted to hospital 2-
3 days prior to the surgery. Surgery is carried out once the patient’s 
sugars are at least sub optimised 22. 
1) Haemoglobin A1c <8% 
2) Before meals values of 80–120 mg% 
3) Before sleep values of 100–140mg% 
Insulin 
There exist numerous intraoperative regimen for administering 
insulin – intravenous infusion, infusion bolus, subcutaneous and various 
subcategories within.  
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Subcutaneous insulin is mostly shunned for perioperative glucose 
control as it is marked by erratic absorption and unsatisfactory control. 
Among the many intravenous regimen the most commonly followed are 
the combined glucose and insulin infusion of Alberti and Thomas and the 
insulin infusion regimens of Watts et al where the glucose runs separate 
from insulin3. Administration of glucose is necessary to provide for the 
basal glucose requirement, which is 1.2 mg/kg/min (roughly 5 g/h). Many 
of the regimens add potassium to the mix to account for the translocation 
of potassium into cells in response to insulin.  
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REVIEW OF LITERATURE 
Anaesthetic management of patients with diabetes mellitus6 
G. R. McAnulty, H. J. Robertshaw and G. M. Hall 
Oxford Journals Medicine & Health BJA Volume 85, Issue 1Pp. 
80-90 British journal of anaesthesia 85 (1) : 80-90 (2000) 
This review discusses some of the latest developments in the field 
of diabetes mellitus. Over the past few years evidence has been gathered 
that improving blood glycaemic control in both the short and long term 
improves the outcome of surgery. Attention to detail in the everyday 
management of the disease and it’s associated conditions, such as 
hypertension, decreases the devastating consequences of microvascular 
and macrovascular complications. Additionally, a more aggressive 
approach to glycaemic control in the perioperative period results in better 
wound healing, reduced morbidity and a shorter duration of hospital 
stays. The days when anaesthetists could tolerate ‘permissive 
hyperglycaemia’ with the thought that this approach was in the patient’s 
best interest, are gone. Tight metabolic control in the perioperative period 
is necessary and is a goal which is attainable in most patients.  
With the introduction of new innovations in monitoring, exact 
measurement of capillary as well as blood sugars is possible at hospital 
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level. According to recent findings the measurement of circulating beta 
hydroxyl butyrate concentrations can be of use in complicated diabetes 
mellitus and will be much facilitated with the development of a device for 
the same which can be used at bed side. The article also states that 
measurement of glycosylated haemoglobin has little value in the 
perioperative period. However, it is definitely of great value in assessing 
the blood glucose control over a long time.  
Intensive Insulin Therapy in Critically Ill Patients23 
The New England Journal of Medicine 
Van den Berghe: N Engl J Med, Volume 345(19).November 8, 
2001.1359-1367 Van den Berghe et al 
The trial aimed at finding a significant association between 
intensive blood sugar control by insulin therapy and decrease in deaths in 
the ICU, which was till then a barely treaded area of management.  
Methods -A prospective, controlled and randomised study was 
performed on adult patients requiring positive pressure ventilation in the 
surgical ICU. Assignment to groups receiving narrow range insulin 
treatment (maintenance of glycaemic level in a range of 80 and 110 
mg/dl) or conventional treatment (providing insulin in the case that blood 
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sugar level crosses 215 mg/dl and keeping the glucose at a level in a 
range of 180 and 200 mg/dl) was random.  
Results: After a study of 12 months, with a total of 1548 sample 
size, it was found that intensive insulin therapy decreased mortality in the 
course of intensive care from 8.0 percent with conventional treatment to 
4.6 percent The benefit of strict blood sugar control could be attributed to 
its effect on death in the group of patients who were in the ICU for 
beyond 5 days (20.2 percent with conventional treatment, as compared 
with 10.6 percent with intensive insulin therapy; P=0.005). The highest 
decrease in death comprised of deaths due to sepsis and associated 
MODS. Strict control of blood glucose also lessened the overall number 
of deaths in the hospital setup by a measure of 34 percent, infections in 
the blood by 46 percent, ARF in need of dialysis or hemofiltration by a 
measure of 41 percent, the number of PRBC transfusions by a measure of 
50 percent, and critical-illness polyneuropathy of critical illness by a 
measure of 44 percent. The above patients were also found to be 
weanable faster from the ventilator and requiring lesser duration of 
special care.  
The study trial concluded that keeping the glycaemic levels less 
than, or equal to 110 mg% was linked to lesser number of deaths and 
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faster recovery in the study population which comprised of ICU patients 
belonging to the department of surgery.  
Perioperative Management of Diabetes16 
Jennifer B. Marks, M.D., University of Miami School of Medicine, 
Miami, Florida Am Fam Physician. 2003 Jan 1;67(1):93-100. 
Even though opinions vary, and there is very little information to 
say that so and so protocol or approach to handling diabetic patients 
during surgery is superior, it is obvious that if the control of blood sugars 
is maintained tightly during the perioperative period, the end result of the 
surgery will be satisfactory in terms of wound healing and avoidance of 
sepsis. The anaesthetist should be well acquainted with the medications 
being used by the patient, the quality of control of the disease and any 
other factors that might influence the sugar levels during surgery. 
In the opinion of the author, if there exists any doubt as to whether 
to give insulin or not or how much of insulin to give, it is more prudent 
administer it rather than withhold because hypoglycaemia can be easily 
avoided by co administering glucose with insulin but the complications of 
hyperglycaemia are difficult to deal with. DKA and hyperglycaemic 
hyperosmolar conditions take up a lot of energy and time to treat, which 
could be better spent on dealing with the more demanding anaesthetic 
 17 
aspects of managing major surgeries. One has to focus on certain factors 
on a priority basis if the plan of action for dealing with diabetes is to be 
successful. Checking the blood glucose values often and likewise 
assessing the levels of electrolytes, volemic status, and pH are some of 
these. With diligent handling of the glycaemic status of the patient many 
post operative complications of surgery can be successfully avoided.  
A Simple Glucose Insulin Regimen for Perioperative Blood Glucose 
Control: The Vellore Regimen3 
Ann Miriam, MD, and Grace Korula, MD Department of 
Anaesthesia, Christian Medical College Hospital, Vellore, India 
(AnesthAnalg2004; 99: 598–602) 
The study aimed at finding a convenient way of controlling blood 
sugar intra operatively. The Vellore regimen, was created to combine the 
advantages of a combined glucose insulin regimen like the Alberti 
regimen as well as variable rate infusion e.g. Watt’s regimen. Thus the 
cumbersome technique of the former, and the sophisticated equipment 
and the risks of the latter were done away with. For every 1-50 mg% rise 
in blood glucose concentration > 100mg/dl, a single unit of insulin was 
put through the injection port of the burette containing 100 ml of 5 % 
dextrose. The blood glucose values were checked every hour. 204 
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patients were randomly put into 2 groups, 98 in the group for the Vellore 
regimen, 106 in a group where the anaesthetist was free to choose a 
technique of his choice. The blood sugar values were then compared. The 
mean + SD blood glucose value of the study group was 156 + 35mg%, 
while the value of the second group was 189 + 64 mg/d (P=0.003). With 
the new regimen the percentage of patients whose sugars were not well in 
control decreased from 51% to 28 %as compared to the control group 
which saw it rise from 49 % to 73 %. (P =0.013). It was concluded that 
the Vellore regimen is easy and convenient for blood glucose control 
during surgery.  
Continuous Perioperative Insulin Infusion Decreases Major 
Cardiovascular Events in Patients Undergoing Vascular Surgery5 
A Prospective, Randomized Trial Balachundhar Subramaniam, 
M.B.B.S., M.D et al Copyright © 2009, the American Society of 
Anesthesiologists Anesthesiology 2009; 110:970–7 
The prospective study trial compared a continuous intraoperative 
insulin regimen with a regimen of intermittent iv bolus based on a sliding 
scale within a group of 236 patients who were undergoing vascular 
surgery, and came to the conclusion that intravenous administration of 
insulin when given continuously, will mostly cause less change in blood 
sugar concentrations when contrasted with either bolus subcutaneous or 
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bolus intravenous insulin dosage. Reduced change of glycaemic levels 
may explain the fact that the standard deviation of glucose levels was less 
in the continuous infusion group, in contrast to the bolus insulin group, 
from 8 h after surgery until 24 h. Although, there was no significant 
difference in the mean for both the groups. Also, the incidence of major 
cardiovascular events postoperatively was found to be more in the second 
group. In conclusion, continuous insulin infusion was found to reduce 
perioperative myocardial infarction after vascular surgery. 
Perioperative Blood Glucose Monitoring in the General Surgical 
Population22 
Tejal A. Raju, M.D., Marc C. Torjman, Ph.D., and Michael E. 
Goldberg, M.D. 
J Diabetes Sci Technol. 2009 Nov; 3(6): 1282–1287. Published 
online 2009 Nov. PMCID: PMC2787027 
An association between poor surgical results and diabetes mellitus 
which is not under control, has been shown to exist, more so in major 
surgeries like cardiac and brain. However a significant study also found 
out that maintaining blood sugar levels within a narrow range of 80-110 
mg% was actually harmful and caused increased deaths. Based on several 
other controlled studies it was concluded that maintaining glycaemic 
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levels between 140 – 180 mg % was better for the patient. Among the 
many factors that affect blood glucose levels perioperatively, are the 
manner of use of blood sugar reducing medications preoperatively, 
titration of insulin intraoperatively and the type of surgery and 
anaesthesia used. It is advised that the damage can be reduced by not 
allowing wide fluctuations in the blood sugar levels perioperatively.  
Perioperative blood glucose monitoring and control in major 
vascular surgery patients12 
J.P.Vankuijk, O. Schouten, W. J. Flu, C.A.denUil, J.J.Bax, D. 
Poldermans 
Eur J VascEndovascSurg (2009) 38, 627-634 
The article delves into studies aimed at looking into the effects of 
intensive blood glucose lowering therapies. It was found out that although 
earlier studies showed a reduction in morbidity and mortality with such 
an approach, later studies could not confirm the same. Based on the 
review of existing literature, they came to the conclusion that narrow 
range control of glucose, perioperatively, could be harmful in some cases 
while not causing the intended benefit in many.  
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Creating a Perioperative Glycemic Control Program21 
Sara M. Alexanian, Marie E. Mcdonnell, and Shamsuddin Akhtar 
Anesthesiology Research and Practice 
Volume 2011 (2011), Article ID 465974 
The review, while accepting the practitioners’ challenge of 
managing patients with diabetes mellitus during the whole process, also 
notes that in this time, especially when the patient is treated by multiple 
faculties, a lot of transitions in care occur between the involved 
specialities, which can be detrimental in the sense that there is great scope 
for miscommunication and loss of important information. An option 
provided is the formation of a team which includes personnel from the 
various specialities, thus minimising the above mentioned errors. The 
article also notices that there is no approach that can be generally applied 
to all the patients uniformly and treatment should be rather 
individualised. Our understanding of the whole subject is still not in it’s 
advanced stages and much research needs to be done to resolve several 
disputed issues regarding management. There is no doubt however that 
the goal will be achieved sooner rather than later, if one considers the rate 
at which science is progressing.  
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Diabetes Mellitus in Anaesthesia13 
JadelisGiquel; Yiliam F Rodriguez- Blanco; Christina Matadial; 
Keith Candiotti 
British Journal of Diabetes and Vascular Disease. 2012;12(2):60-
64. 
It is too often that one comes across patients suffering from type 2 
diabetes mellitus, that too in an uncontrolled state. Undergoing 
anaesthesia and surgery is not without it’s fair share of risks for these 
patients. Some of them present in advanced stages of damage to vital 
organs – myocardial ischaemia, infarction, transient ischaemic attacks, 
diabetic retinopathy, diabetic nephropathy, stroke are but few of the 
bothersome conditions that plague diabetics, not to mention the 
suppressed immunity that can undo the purpose of surgery by inviting 
lecherous infections that are difficult to treat. Having such a huge 
significance with respect to morbidity and death, it is one of the many 
conditions that the anaesthesiologist must be thoroughly familiar with. 
He/she should be able to identify what investigations are needed and not 
hesitate to order for them.  
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Glycaemic control in the perioperative period11 
J. J. Sebranek, A. Kopp Lugli and D. B. Coursin 
British Journal of Anaesthesia 111 (S1): i18–i34 (2013) 
Doi:10.1093/bja/aet381 
According to the review, the preponderance of evidence confirms 
the undesirable end effects on the patient of pathological glucose 
metabolism. The anaesthetist is totally responsible for the complete 
management of DM, right from detection, investigation to appropriate 
management because of it’s effect on so many aspects of anaesthesia and 
the dire consequences of ignoring it. given the fact that the diabetic group 
comprises of people of varied nature it is natural that a single regimen 
won’t be applicable to all and every individual must be treated according 
to his or her specific nature of disease and it’ complications. In certainty, 
if the disease is diagnosed early and it’s treatment commenced at the 
earliest then the anaesthetic as well as surgical risks will be very much 
reduced. Even though there is no strong consensus about it, the target 
range of intraoperative blood glucose hangs within the territory bound by 
intensive control on one extreme and allowance of raised blood sugar 
levels on the other; the aim being acceptable control and prevention of 
fall in blood sugars. Future investigations should help identify specific 
perioperative glucose targets, especially in specialized surgical 
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populations (i.e. Cardiac, neurosurgical), while advances in monitoring 
and medications will make it easier to achieve specific glucose targets in 
individual patients.  
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MATERIALS AND METHOD 
Ethical approval 
The protocol of the study was accepted by the medical ethical 
committee of madras medical college, affiliated to The Tamil Nadu MGR 
University. The protocol was overseen by the concerned guides and the 
concerned head of the departments. Approval was also sought from the 
department of diabetology.  
Trial design 
A prospective randomised controlled trial in adult patients with 
type 2 diabetes mellitus coming for vascular surgery, to evaluate the best 
treatment algorithm to lower blood glucose in the intraoperative setting, 
utilizing two parallel study arms. One group was allotted for the Vellore 
regimen while the other had an intermittent intravenous bolus regimen of 
insulin, based on a sliding scale, chosen for it. Sample size was 
determined based on the Study - 
A Simple Glucose Insulin Regimen for Perioperative Blood 
Glucose Control: The Vellore Regimen 
Authored by Ann Miriam, MD, and Grace Korula, MD 
Published in (AnesthAnalg 2004;99:598–602)  
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In this study group’s value was 189 63 mg/dL (P 0.003) the 
percentage of patients who were poorly controlled (outside 100 to 200-
mg/dL range) decreased from 51% to 28% (no patient less than 60 
mg/dL) with this regimen as compared with the control group in which it 
increased from 49% to 72% (10 patients less than 60 mg/dL) (P 0.0013).  
Description: 
 The confidence level is estimated at 95% 
 with a z value of 1.96 
 the confidence interval or margin of error is estimated at +/-10 
 Assuming that 23 percent of the sample will have the specified 
attribute p% =23.00 and q%=77.00 
n = p% x q% x [z/e%] ² 
n= 23 x 77 x [1.96/5]² 
n= 68.03 
Therefore 68 is the minimum sample size required for the 
study(n=34 in intervention arm and n=34 in control arm) 
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Inclusion criteria 
1. Signed informed consent 
2. Known case of type 2 diabetes mellitus 
3. On treatment with insulin, either chronically or switched 
over perioperatively 
4. Scheduled for elective vascular surgery  
5. Surgery lasting for more than 2 hours 
6. Age between 25 – 60 years 
7. ASA PS 2, 3, 4 
8. Anaesthesia – regional / general 
Exclusion criteria 
1. Not satisfying inclusion criteria 
2. Moribund patients  
3. Emergency surgery 
4. Patients on steroids 
5. Diabetic ketoacidosis 
6. Well controlled diabetes not requiring insulin 
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After obtaining ethical committee approval and informed consent 
from patients, I studied 70 patients, divided into the 2 study groups. The 
patients were recruited during a preassessment visit at the department of 
anaesthesiology. Here, oral information about the study was provided to 
prospective subjects, following which written consent for participation in 
the trial was obtained. The chosen patients were randomised into one of 
the 2 study arms in a 1:1 ratio. The sample size was chosen based on 
calculated statistically significant sample size using previous similar 
studies. The study intended to take into account the stress factor involved 
in surgery and its effect on the comparisons that were to be made. Hence 
the subgroup of patients undergoing vascular surgery was chosen.  
The capillary blood sugar measures taken using the same 
glucometer were considered standard for the trial. The relation between 
blood glucose values between the lab and glucometer was noted. Patients 
from both the groups underwent fasting from midnight before the day of 
surgery. clear fluids were allowed only till 6 hours before surgery. The 
night dose of long acting insulin was reduced to half in all patients. All 
study patients were preferably scheduled for surgery in the morning at 9 
AM. These patients did not receive the morning dose of short acting 
insulin. For patients whose surgery was delayed till afternoon, a glucose 
insulin infusion was started along with hourly blood sugar monitoring. If 
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the blood sugar was found to be less than 70mg%, 100 ml of 5%dextrose 
was rushed and blood glucose was repeated till the value reached above 
70. For a blood glucose level above 70 mg% but below 100 mg%, 100 ml 
of 5%dextrose was given over 1 hour. All other patients having a blood 
glucose level above 100 mg%, received a mixture of 8 IU regular insulin 
in 500 ml 5% dextrose at 100 ml per hour.  
The readings recorded for the statistics were taken at 0, 1, 2, 3 
hours. The 0 reading was taken before induction of anaesthesia, while the 
remaining readings were taken at respective intervals from the 
commencement of anaesthesia, till the patient left the recovery room. 
After returning to the ward the patient was treated for diabetes as per 
ward protocols.  
The Vellore regimen 
For each 1 – 50 mg/dl rise in blood sugar greater than 100mg/dl, 
1U insulin was put into the burette via the port at the side by means of an 
insulin syringe. As 100 ml of 5% dextrose was infused in one hour, the 
level of blood glucose was checked after it. Before starting the infusion, 1 
IU of insulin was put into the burette with 50 millilitres of 5%dextrose 
solution, shaken thoroughly and let run through and out, in order to make 
up for the initial absorption of insulin by the material of the infusion set3.  
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For blood sugar between 70 - 100mg%, only 100ml of plain 
5%dextrose solution was infused over one hour.  
If the blood glucose was found to be less than 70 mg % at any 
point, then 100ml of 55dextrose was rushed and the sugar was rechecked 
after 15 minutes.  
The intermittent intravenous bolus regimen 
This method was based on a sliding scale used in a similar study 
conducted by the PILGRIM trial16. The scale can be demonstrated as a 
table with a column of succeeding higher ranges of blood glucose against 
a column of recommended doses of insulin for the respective blood sugar 
ranges. If the consecutive blood glucose value measured at the end of the 
hour was greater than the last reading then the last column of doses was 
abandoned for a new column carrying higher doses. If not, the column 
used for the last dosing was reused.  
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The Vellore regimen3 
 
Intermittent intravenous bolus regimen16 
Glucose 
measurement 
1st insulin 
bolus 
If glucose rises 
after 1st bolus 
If glucose rises 
after 2nd bolus 
72-144 mg%    
144-162 mg% 2U 4U 6U 
162-180 mg% 3U 5U 7U 
180-198 mg% 4U 8U 12U 
198-216 mg% 5U 9U 13U 
216-234 mg% 6U 12U 18U 
234-252 mg% 7U 13U 19U 
252-270 mg% 8U 15U 20U 
270-288 mg% 9U 16U 21U 
ABOVE 288 
mg% 10U 17U 22U 
  
Blood glucose 
levels 
Treatment regimen 
Below 70mg% 
Stop insulin if on infusion. Rapid infusion of 100 ml 
of D5W. Measure blood glucose after 15 min 
71-100 mg% Stop insulin. Infuse DW5at 100 ml/hr 
101-150mg% 1U of insulin+100 ml D5W/hr 
151-200 mg% 2U of insulin+100 ml D5W/hr 
201-250 Mg% 3U of insulin+100 ml D5W/hr 
251-300 Mg% 4U of insulin+100 ml D5W/hr  
Above 300 mg% 
1U insulin for every 1-50 mg above 100mg% + 
100ml NS/hr 
 32 
It is also necessary to explain here the anaesthetic techniques used 
as it has a bearing upon the results. Either general anaesthesia or regional 
anaesthesia was used depending on the type of surgery. The regional 
anaesthesia given was spinal block, along with epidural anaesthesia. All 
patients received the standard premedications – tab alprazolam 0.25 mg, 
tab perinorm 10 mg and tab ranitidine 150 mg one hour before surgery. 
GA was induced with injection thiopentone and maintained with a gas 
mixture of 35% oxygen in N2O with 1.5 – 2 % of sevoflurane. Analgesia 
was provided with epidural catheter and with intravenous fentanyl 2 
microgram / kg body weight. The maintenance dose used was 20 
micrograms every hour. Patients requiring extensive blood transfusion 
were excluded from the study. Serum potassium was checked every 2 
hours and correction was given if necessary.  
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Statistical Approach 
Primary outcome measures 
The mean with standard deviation of glycaemic readings of each 
hour were calculated within each group and then compared across the 
groups for statistical significance. 
Secondary outcome measures 
The difference in the percentage of people with uncontrolled sugars 
(defined as blood glucose values outside 100 -200 mg %) between hour 0 
and hour 3 was calculated and compared across both the groups.  
Tertiary outcome measures 
The approach used for primary outcome measure was applied only 
to patients with poor pre operative glycaemic control 
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RESULTS 
The randomised study involved comparison of 2 groups, each with 
a sample size of 35 vascular surgery patients. Descriptive statistics was 
done for all data and were reported in terms of mean values and 
percentages. Suitable statistical tests of comparison were done. 
Continuous variables were analysed with the unpaired t test. Categorical 
variables were analysed with the X2 Test and Fisher Exact Test. 
Statistical significance was taken as P < 0.05. The data was analysed 
using SPSS version 16 and Microsoft Excel 2007.  
Before getting down to compare the two groups for the 
aforementioned outcomes, it was necessary to make sure that influence of 
confounding factors was kept to a minimum.  
Comparison of factors like age, sex, type of anaesthesia and pre 
operative glucose control were done.  
  
 35 
 
 
Age 
Distribution 
Insulin Bolus 
Regimen % 
Vellore 
Regimen % 
≤ 40 years 1 2.86 2 5.71 
41-50 years 11 31.43 12 34.29 
51-60 years 23 65.71 21 60.00 
0 0 0.00 0 0.00 
Total 35 100 35 100 
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Age Distribution Insulin Bolus Regimen Vellore Regimen 
N 35 35 
Mean 51.89 51.14 
SD 5.45 6.16 
P value Unpaired t Test 0.5950 
 
Majority of the Insulin Bolus Regimen Group patients belonged to 
the 51-60 years age class interval (n=23, 65.71%) with a mean age of 
51.89 years. In the Vellore Regimen Group patients, majority belonged to 
the same age class interval (n=21, 60%) with a mean age of 51.14 years. 
The association between the intervention groups and age distribution is 
considered to be not statistically significant since p > 0.05 as per unpaired 
t test. 
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Gender 
Distribution 
Insulin Bolus 
Regimen % 
Vellore 
Regimen % 
Male 32 91.43 33 94.29 
Female 3 8.57 2 5.71 
Total 35 100 35 100 
P value Fishers Exact Test 0.6782 
 
Majority of the Insulin Bolus Regimen Group patients belonged to 
the male gender class interval (n=32, 91.43%). In the Vellore Regimen 
Group patients, majority belonged to the same gender class interval 
(n=33, 94.29%). The association between the intervention groups and 
gender distribution is considered to be not statistically significant since p 
> 0.05 as per fisher’s exact test.  
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Type of 
Anaesthesia 
Insulin Bolus 
Regimen % 
Vellore 
Regimen % 
Regional 
Anaesthesia 24 
68.5
7 25 
71.4
3 
General 
Anaesthesia 11 
31.4
3 10 
28.5
7 
Total 35 100 35 100 
P value Fishers Exact Test 0.8013 
 
Majority of the Insulin Bolus Regimen Group patients underwent 
regional anaesthesia (n=21, 68.57%). In the Vellore Regimen Group 
patients, majority similarly underwent regional anaesthesia (n=25, 
71.42%). The association between the intervention groups and type of 
anaesthesia is considered to be not statistically significant since p > 0.05 
as per fishers exact test.  
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Fasting Blood 
Sugar 
Insulin Bolus 
Regimen % 
Vellore 
Regimen % 
≤ 100 mg/dl 1 2.86 1 2.86 
101-110 mg/dl 13 37.14 10 28.57 
111-120 mg/dl 14 40.00 14 40.00 
121-130 mg/dl 7 20.00 10 28.57 
Total 35 100 35 100 
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Fasting Blood Sugar Insulin Bolus Regimen Vellore Regimen 
N 35 35 
Mean 114.26 115.80 
SD 7.79 8.17 
P value Unpaired t Test 0.4216 
 
Majority of the Insulin Bolus Regimen Group patients had fasting 
blood sugar levels in the 111-120 mg/dl class interval (n=14, 40%) with a 
mean FBS of 114.26 mg/dl.. In the Vellore Regimen Group patients, 
majority had fasting blood sugar levels in the 111-120 mg/dl class 
interval (n=14, 40%) with a mean FBS of 115.80 mg/dl. The association 
between the intervention groups and fasting blood sugar measurements is 
considered to be not statistically significant since p > 0.05 as per unpaired 
t test 
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Post Prandial 
Blood Sugar 
Insulin Bolus 
Regimen % 
Vellore 
Regimen % 
≤ 120 mg/dl 2 5.71 0 0.00 
121-160 mg/dl 26 74.29 23 65.71 
161-200 mg/dl 5 14.29 10 28.57 
> 200 mg/dl 2 5.71 2 5.71 
Total 35 100 35 100 
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Post Prandial Blood 
Sugar 
Insulin Bolus 
Regimen 
Vellore 
Regimen 
N 35 35 
Mean 148.51 161.71 
SD 24.89 22.06 
P value Unpaired t Test 0.0218 
 
In patients belonging to Insulin Bolus Regimen Group, the mean 
PPBS measurement is 148.51 mg/dl. In Vellore Regimen Group, the 
mean PPBS measurement is 161.71 mg/dl. The increased mean PPBS 
measurement in Vellore Regimen Group compared to the Insulin Bolus 
Regimen Group is statistically significant as the p value is 0.0219 as per 
unpaired t- test indicating a true difference among study groups.  
However, the post prandial blood sugar is only one of the many 
variables used in assessing the quality of blood glucose control and since 
the fasting blood glucose values analysis did not show any significant 
difference between the two groups, it is safe to consider that the 2 groups 
did not significantly differ in terms of preoperative blood glucose control.  
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Primary Outcome Measure 
Blood glucose monitoring at hourly intervals in both the groups 
 
 
Blood Glucose 
Monitoring Baseline 1 hour 2 hour 3 hour 
Insulin 
Bolus 
Regimen 
N 35 35 35 35 
Mean 156.37 158.09 157.51 152.06 
SD 34.09 37.17 34.23 30.22 
Vellore 
Regimen 
N 35 35 35 35 
Mean 159.97 146.89 143.69 139.97 
SD 35.00 35.16 17.54 18.17 
P value Unpaired t Test 0.6643 0.1997 0.0367 0.0383 
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Results  
In patients belonging to Insulin Bolus Regimen Group, the mean 
blood sugar measurement ranged from 156.37 mg/dl at baseline to 152.06 
mg/dl at the end of 3 hours. Similarly in the Vellore Regimen Group, the 
mean blood glucose measurement ranged from 159.97 mg/dl at baseline 
to 139.97 mg/dl at the end of 3 hours. The mean blood glucose 
measurement at each hour was compared in both the groups. The 
decreased mean blood glucose measurement in Vellore Regimen Group 
compared to the Insulin Bolus Regimen Group is statistically significant 
as the p value is 0.0367 at 2 hours and 0.0383 at 3 hours intraoperatively 
as per unpaired t- test indicating a true difference among study groups.  
Discussion  
The mean BS measurement intraoperatively at 2-3 hours was 
meaningfully less in Vellore Regimen Group compared to the Insulin 
Bolus Regimen Group by 12.96 mg/dl. This significant difference of 8% 
decrease in mean blood glucose measurement intraoperatively in Vellore 
Regimen Group compared to the Insulin Bolus Regimen Group is true 
and has not occurred by chance.  
 45 
Conclusion  
In this study we can safely conclude that mean post prandial blood 
sugar measurement was significantly and consistently lower 
intraoperatively in Vellore Regimen Group compared to the Insulin Bolus 
Regimen Group when used to manage intraoperative blood sugar levels.  
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Insulin requirement 
 
 
Insulin Monitoring INS0 INS1 INS2 INS3 
Insulin 
Bolus 
Regimen 
N 35 35 35 34 
Mean 2.20 3.74 3.37 3.91 
SD 1.98 4.01 3.92 4.86 
Vellore 
Regimen 
N 35 35 35 35 
Mean 1.74 1.54 1.49 1.31 
SD 0.78 0.61 0.56 0.47 
P value Unpaired t Test 0.2109 0.0028 0.0079 0.0039 
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Results  
In patients belonging to Insulin Bolus Regimen Group, the mean 
insulin dosage ranged from 2.2 IU at baseline to 3.91 IU at the end of 3 
hours. Similarly in the Vellore Regimen Group, the mean insulin dosage 
ranged from 1.74 IU at baseline to 1.31 IU at the end of 3 hours. The 
decreased mean insulin dosage in Vellore Regimen Group compared to 
the Insulin Bolus Regimen Group is statistically significant as the p value 
is 0.0028 at 1 hour, 0.0079 at 2 hours and 0.0039 at 3 hours 
intraoperatively as per unpaired t- test indicating a true difference among 
study groups.  
Discussion  
The mean insulin dosage intraoperatively between 1-3 hours was 
meaningfully less in Vellore Regimen Group compared to the Insulin 
Bolus Regimen Group by 2.24 IU. This significant difference of 62% 
decrease in mean insulin dosage intraoperatively in Vellore Regimen 
Group compared to the Insulin Bolus Regimen Group is true and has not 
occurred by chance.  
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Conclusion  
In this study we can safely conclude that mean insulin dosage was 
significantly and consistently  
Lower intraoperatively in Vellore Regimen Group compared to the 
Insulin Bolus Regimen Group when used to manage intraoperative blood 
sugar levels 
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Secondary Outcome Measure 
Number of Intraoperative Glucose Values outside the 100–200 mg 
Range
 
 
Number of Intraoperative Glucose 
Values outside the 100–200 mg Range 
Hour 0 % Hour 3 % 
Insulin Bolus Regimen 6 17.1 2 5.7 
Vellore Regimen 8 22.8 0 0% 
P value Fishers Exact Test 0.2333 
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In patients belonging to Vellore Regimen Group, the number of 
intraoperative glucose levels external to the 100–200 mg range between 
hour 0 is 42.86% (n=6). In patients belonging to Insulin Bolus Regimen 
Group, the number of intraoperative glucose values external to the 100–
200 mg range hour 3 is 100% (n=2). The increased the number of 
intraoperative glucose levels external to the 100–200 mg range between 
hour 0-3 in Vellore Regimen Group at hour 0 and at hour3 in Insulin 
Bolus Regimen Group is statistically not significant as the p value is > 
0.05 as per unpaired t- test. 
In comparing the difference between the number of patients who 
were outside the target range at hour 0 and hour 3 between both the 
groups every hour, we find that for the Vellore regimen, the percentage 
dropped from 63% to 0%, while for the insulin bolus regimen it 
decreased from 17 % to 5 %.  
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Tertiary Outcome Measure 
Blood glucose monitoring of patients who had poor control at 
assessment 
 
 
Blood Glucose Monitoring of Patients 
who had Poor Control at Assessment  
( FBS≥126, PPBS≥200) 
BS0 BS1 BS2 BS3 
Insulin Bolus Regimen 
N 5 5 5 5 
Mean 211.00 195.80 176.80 160.60 
SD 9.85 31.25 54.03 41.03 
Vellore Regimen 
N 4 4 4 4 
Mean 210.75 202.00 179.50 142.75 
SD 8.62 37.27 37.68 20.12 
P value Unpaired t Test 0.9688 0.7992 0.9323 0.4262 
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In patients belonging to Insulin Bolus Regimen Group, the mean 
Blood Glucose Monitoring of Patients who had Poor Control at 
Assessment (FBS≥126, PPBS≥200) ranged from 211 mg% at baseline to 
160.60 mg% in the culmination of 3 hours. Similarly in the Vellore 
Regimen Group, the mean BS measurement ranged from 210.75 mg/dl at 
baseline to 142.75 mg/dl at the end of 3 hours. The decreased mean 
Blood Glucose Monitoring of Patients who had Poor Control at 
Assessment (FBS≥126, PPBS≥200) in Vellore Regimen Group compared 
to the Insulin Bolus Regimen Group is statistically not significant as the p 
value is > 0.05 as per unpaired t- test. 
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Comparison of the number of patients whose blood glucose values 
crossed below 60 mg % and above 225 mg% in the course of the 
study in both the groups 
Comparison between the two groups for the number of patients 
found to be having blood glucose levels < 60 mg% and > 225mg%. There 
was no instance of drop in blood sugar below 60 mg% in the Vellore 
regimen group while there was one such episode in the insulin bolus 
regimen group. The patient was treated with rapid infusion of 100 ml of 5 
% dextrose over 15 minutes and reassessed. Further treatment was 
continued as per the respective regimen. Also the number of people with 
blood sugars above 225mg% was 3 in the Vellore regimen group while 
the intermittent iv bolus regimen had 8 such patients.  
 
 H0 H1 H2 H3 
Vellore 
regimen 
<60 0 
>225 0 
<60 0 
>225 2 
<60 0 
>225 1 
<60 0 
>225 0 
Insulin bolus 
<60 0 
>225 0 
<60 0 
>225 4 
<60 1 
>225 2 
<60 0 
>225 2 
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DISCUSSION  
Blood glucose control in the diabetic patient undergoing major 
surgery is of utmost importance. Control of blood sugars is imperative for 
the proper management of diabetic patients and is shown to reduce the 
occurrence of not only microvascular complications but also the 
neurological ones that are common. However, evidence doesn’t show the 
expected fall in the occurrence of macrovascular damages, which are 
likely linked to associated conditions like hypertension, smoking and 
poor dietary / lifestyle choices6.The latter finding is supported by the 
observation that patients suffering from both DM as well as hypertension 
show reductions in risk of complications of DM and death due to 
macrovascular damages and ocular damage if they are managed with 
ACE inhibitors or beta blockers. Type 2 DM patients who are undergoing 
minor surgery need not be started on insulin if the planned surgery is a 
minor one. All DM patients who are about to undergo major surgery and 
are either on oral hypoglycaemic drugs or on insulin must definitely start 
receiving insulin before surgery. Using a continuous intravenous infusion 
of insulin is a better option compared to intermittent subcutaneous bolus 
regimens and may be associated with better end results. Intermittent 
intravenous bolus regimens are also accepted and are in use6. However, 
the protocol used to the end result should be simple and convenient, as 
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time and concentration has to be devoted to so many other major 
anaesthetic challenges one faces in such cases. The Vellore regimen was 
devised to suit the above concern and has been quite accepted in our daily 
practice. In doing this trial, I intend to ascertain whether the even more 
convenient intermittent intravenous bolus regimen, based on a sliding 
scale, provides glycaemic control benefits comparable to the usually 
followed insulin infusion regimen.  
In our institute, we don’t follow a single regimen for the purpose of 
blood glucose control. The method adopted depends on the 
anaesthesiologist, and can vary from giving subcutaneous insulin to 
resorting to insulin only in instances of hyperglycaemia. Convenience is 
necessary for any regimen to be successful.  
The insulin used was regular human insulin. The rationale of 
supplying insulin in dextrose is that the body needs glucose for baseline 
energy requirements which is around 1.2 mg/kg/min i.e. 5 g/hour, as 
narrated by Hirsh10, Meyer and White. As discussed earlier, the body 
needs glucose for it’s, basal metabolic requirements. These studies have 
also shown that most of the times patients can be kept within the blood 
sugar range of 120-180 mg% using an insulin  
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Infusion rate between 1 -2 IU per hour16. The insulin dose was 
mixed with water prior to introducing it into the burette so that no drug 
was wasted.  
 
 
There is a tendency for considerable quantities of insulin to adsorb 
on infusion sets, especially if the sets are long, consequently decreasing 
the starting velocity of delivery of insulin if the protocol that is used has a 
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solution with more volume compared to the insulin dose21. Person et al 
found that a washout of about fifty ml with a solution containing twenty 
five IU of regular insulin in five hundred ml of normal saline allows 
seventy five percent of expected drug for the first 50 ml of the infusion 
and hundred percent after that. I put one ml of the drug into ten ml of 
dextrose solution, rinsed the burette and threw it out prior to commencing 
the infusion, in an attempt to minimise  
The above described effect of adsorption. A detailed look at the 
master chart shows the blood sugars stabilising well in the latter hours, 
which may be attributed to the wearing off of the adsorption effect3.  
Potassium was not included in the Vellore regimen because unlike the 
Alberti regimen where 10% dextrose was used, the Vellore regimen used 
5% dextrose and hence the demand for insulin was reduced3. However, 
monitoring of serum Potassium was done at least 2 hourly 
intraoperatively, especially in very long duration procedures, and 
appropriate treatment was promptly instituted.  
The target range for blood glucose control was chosen as 100-
200mg%3. In this whole exercise it is of prime importance that 
hypoglycaemia is avoided at all costs, as the complications are potentially 
disastrous, the worst case scenario being hypoglycaemic coma and 
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cardiac arrest. It is also not so easy to suspect hypoglycaemia in a patient 
under general anaesthesia.  
The purpose of this study trial was to converge on an appropriate 
regimen that was both effective as well as convenient. While the Vellore 
regimen has proven it’s efficiency in some previous trials, there are very 
few studies undertaken to make a comparison of it with the more popular 
but controversial intermittent intravenous bolus regimen of insulin. The 
study was conducted in vascular surgery patients, who have a very 
common association with the disease.  
For analysing the statistics, our outcome measures were as follows 
1. Primary – comparison between the two groups of mean +- 
standard deviation of intraoperative blood glucose on an hourly 
basis.  
2. Secondary – comparing the difference between the number of 
patients who were outside the target range(100mg% - 200mg%) at 
hour 0 and hour 3 between both the groups 
3. Tertiary – comparison between the two groups of mean+- 
standard deviation of intraoperative blood glucose on an hourly 
basis, only for those patients who had poor preoperative blood 
glucose control ( FBS>126 mg%, PPBS>200mg%) 
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Based on the analyses, the following were the findings 
The primary outcome showed a significant difference between the 
two regimen, in favour of the Vellore regimen. The mean blood glucose 
measurement at each hour was compared in both the groups. The 
decreased mean blood glucose measurement in Vellore Regimen Group 
compared to the Insulin Bolus Regimen Group is statistically significant 
as the p value is 0.0367 at 2 hours and 0.0383 at 3 hours intraoperatively 
as per unpaired t- test indicating a true difference among study groups. 
For the secondary outcome, in comparing the difference between 
the number of patients who were outside the target range at hour 0 and 
hour 3 between both the groups every hour, we find that for the Vellore 
regimen, the percentage dropped from 63% to 0%, while for the insulin 
bolus regimen it decreased from 17 % to 5 %. Although the Vellore 
Regimen takes the upper hand here, the finding was not found to be 
statistically significant.  
Coming to the tertiary outcome, In patients belonging to Insulin 
Bolus Regimen Group, the mean Blood Glucose Monitoring of Patients 
who had  
Poor Control at Assessment (FBS≥126, PPBS≥200) ranged from 
211 mg/dl at baseline to 160.60 mg/dl at the end of hour 3. The 
comparison turned out to be insignificant although it was in favour of the 
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Vellore regimen. The mean blood glucose measurement varied from 
210.75 mg/dl at baseline to 142.75 mg/dl at the end of hour 3. The 
decreased mean Blood Glucose Monitoring of Patients who had Poor 
Control at Assessment (FBS≥126, PPBS≥200) in Vellore Regimen Group 
compared to the Insulin Bolus Regimen Group is statistically not 
significant as the p value is > 0.05 as per unpaired t- test.  
An overview of the complications that occurred during the surgery 
is also important to take into consideration the safety of each of the 
regimen Therefore, I also undertook a comparison between the two 
groups for the number of patients found to be having blood glucose levels 
< 60 mg% and > 225mg%. There was no instance of drop in blood sugar 
below 60 mg% in the Vellore regimen group while there was one such 
episode in the insulin bolus regimen group. The patient was treated with 
rapid infusion of 100 ml of 5 % dextrose over 15 minutes and reassessed. 
Further treatment was continued as per the respective regimen. Also the 
number of people with blood sugars above 225mg% was 3 in the Vellore 
regimen group while the intermittent iv bolus regimen had 8 such 
patients. The comparison attests to the safety of the Vellore regimen.  
As a side note, it was also observed that the Vellore regimen 
consumed less insulin to give better control over blood sugars than the 
intermittent iv bolus regimen.  
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Comparing my study with similar studies done previously, I found 
that the results were similar, being in favour of insulin infusion regimens 
for intra operative glycaemic control. The trail on which my study was 
primarily based was ‘A Simple Glucose Insulin Regimen for 
Perioperative Blood Glucose Control: The Vellore Regimen ‘conducted 
at CMC, Vellore. It compared the Vellore regimen in the study group 
with many commonly used regimens in the control group3. Another trial’ 
Continuous Perioperative Insulin Infusion Decreases Major 
Cardiovascular Events in Patients Undergoing Vascular Surgery’ did a 
similar comparison between continuous and intermittent approaches of 
insulin administration and found the former to be superior5.  The 
PILGRIM trial is currently conducting a study comparing the GIK 
regimen, the intermittent IV insulin bolus regimen and GPL pre-treatment 
with liraglutide16.  
Preoperative Evaluation 
All diabetic patients should undergo a thorough evaluation of all 
aspects of the disease right from a detailed history covering the onset, 
duration progress, medications and complications to examination and 
investigations. The assessment for complications should focus on all 
expected affected systems. The cardiac system may not show symptoms 
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of myocardial ischaemia due to peripheral neuropathy, hence a baseline 
ECG is a must16. On further suspicion one may proceed with stress 
testing, ECHO, angiography.  
Renal evaluation is also important and includes seeking history of 
facial puffiness, signs of water retention, hypertensionetc. Renal function 
tests are necessary16. Serum creatinine isn’t very reliable as an indicator 
of renal dysfunction because values remain normal till at least half the 
nephron function is lost. A twenty four hour urine creatinine estimation is 
a more sensitive indicator. Proteinuria and defective creatinine clearance 
in a diabetic patient could signal chances for occurrence of ARF 
perioperatively.  
Orthostatic hypotension is another concern which may foreshadow 
intraoperative haemodynamic instability. Other signs of autonomic 
neuropathy such as resting tachycardia and loss of normal respiratory- 
heart rate variability must be sought. The patient should then be 
optimised by approaching those problems that can be corrected like for 
example, the blood sugar levels, the acid base status and electrolyte 
abnormalities. The above measures play a crucial role in the final 
outcome of the surgery 16. 
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Glycaemic control 
Most patients, especially those undergoing major surgery, are 
hospitalised 2 -3 days before surgery for optimising glucose control.  
In order to achieve quality control we need to check blood glucose 
levels quite often and adjust the dosages on insulin accordingly. This is 
shown to achieve stability in the glycaemic levels. The recommendations 
of timings in which to carry out the monitoring, include before meals, 
post meals and before sleep. In patients on insulin, the long acting insulin 
must be withheld 24-48 hours prior to surgery. The alternative would be 
giving a combination of intermediate acting insulin with a short acting 
one, twice a day or giving short acting insulin prior to all meals. 
However, on the day before surgery, long-acting insulin may be used 
throughout the day if the patient's control is fine, especially if the patient 
is on glargine. Because this recently introduced insulin analogue keeps a 
steady concentration in the course of the day, more experience with its 
utilisation may perhaps show its safety as a basal insulin in the course of 
the surgical period16. 
Oral agents are generally stopped before surgery, except for minor 
procedures where the patient is going to start eating soon after surgery, 
and changed to insulin. Long-acting OHA’s are stopped two to three days 
before surgery, while short-acting sulfonylureas, other insulin 
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secretagogues, and metformin should be withheld the night before or the 
day of surgery16. There exist no suggestions for use of thiazolidinediones 
prior to surgery; their prolonged duration of action is a good enough 
reason to avoid them perioperatively.  
Intraoperative Management 
Insulin 
 
 
The word insulin derives from the Latin word insula which means 
island and is called so because it is produced by the island like beta cells 
of the pancreas. it is an anabolic hormone that is involved in such crucial 
metabolic activities as  
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1. Skeletal muscle and fat absorption of glucose from blood,  
2. Storage of fat and inhibition of lipolysis,  
3. Inhibition of gluconeogenesis  
Normally, constant baseline levels of insulin are released into 
blood, to control blood glucose levels. Glucose, which is the main fuel for 
life can also be destructive in higher concentrations. Whenever glycaemic 
levels reduce beyond a certain extent, the body utilises glycogen as an 
energy source via the process of breakdown of glycogen, which involves 
breaks down the glycogen stored in the liver and muscles into glucose, so 
that it can be used as a fuel  
Patients with type 1 diabetes have their source of insulin destroyed 
due to autonomic complications and therefore depend on externally 
provided insulin for life.  
Patients with type 2 DM on the other hand, initially develop insulin 
resistance due to poorly known factors and later exhaust their source of 
insulin supply over a period of years due to the persistently high 
stimulation of the islet cells. These patients in the long run require insulin 
if lifestyle changes and OHA’s fail to get the blood glucose levels under 
control. A little less than half of the patients with Type 2 diabetes need 
their blood sugars to be controlled by insulin. 
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Insulin is thought to be an ancient protein that possibly originated 
more than a billion years ago. Molecular structures that might be 
precursors to insulin have been found even in the simplest unicellular 
organisms. Insulin-like proteins have also been demonstrated in Fungi.  
The make up of insulin is not the same in all the species but differs 
in small ways. as opposed to human insulin, animal insulin has somewhat 
different effects on the metabolism of carbohydrates on account of the 
differences in structure. The human insulin resembles porcine insulin 
very closely.  
Gone are the days when we would use animal insulin to inject into 
humans. Modern medicine uses recombinant DNA technology to create 
bio synthetic insulin. With this new advent, it was possible to avoid 
complications of animal insulin like allergy and resistance due to 
antibody formation.  
A recent technique of producing insulin involves introducing the 
human insulin gene in plants e.g. Sunflower to produce insulin, in a 
technique called bio farming. This is sure to markedly reduce costs.  
As of today, there are many analogues of insulin. Insulin analogues 
are modifications of human insulin that are developed and engineered to 
cater to specific aspects of desired pharmacokinetics. The first 
biosynthetic insulin analogue was createdespecially for clinical use at the 
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time of meals, Humalog (insulin lispro), it starts taking effect at around 
15 mins. The route of administration is subcutaneous. It is absorbed into 
the body much faster than subcutaneously injected regular insulin. Other 
analogues which act similarly in terms of onset of action are novo rapid 
and aprida. These have related pharmacokinetic outline. Because of a 
sequence that decreases the generation of dimers and these insulins are 
quickly absorbed. Insulins which form monomers are absorbed faster. 
Fast acting insulins no longerneed to be administered before meals by a 
certain time interval as it was previously required for human insulin and 
animal insulins. There also exist insulins that have prolonged periods of 
action ; the first of the long acting types was Lantus (insulin glargine). 
Their effect lasts from a period of 18 – 24 hours. the most common route 
of administration of insulin is the subcutaneous one. The dose is delivered 
by insulin syringes or pumps or insulin pens that have needles which can 
be disposed. Technology is advanced to such an extent that insulins 
which are administered via the inhalational route have now appeared in 
the market.  
Insulin is a protein and hence cannot be taken orally, which if done, 
it will be broken into amino acids with resultant loss of it’s function. 
There is testing going on into ways to safeguard insulin within the GIT, 
making it possible to be administered via the oral or sublingual route. 
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Although this endeavour is still in it’s infancy various of such drugs are 
being tested in human trials and preparations are on to launch the 
products.  
 
 
There still exists no 100% certainty about which method is best for 
perioperative blood glucose control. Few studiesexplicitlyindicate the 
supremacy of one protocol over another. Any protocol should 
a) Sustain good blood sugar regulation to prevent extreme variations 
in glycaemic status, which is the main goal of the whole exercise 
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and is the factor upon which the success of the protocol is 
dependant 
b) Avoid other metabolic and electrolyte interferences that may arise, 
for example, dangerous hypokalaemia may occur after long 
duration insulin infusions  
c) Be comparatively simple to comprehend. The above quality cannot 
be overlooked because sugar control is one small component of a 
much larger anaesthetic management plan.  
d) Be usable in a wide range of circumstances.  
For any regimen to be successful, it has to be able to promptly find 
out any changes in metabolic regulation and rectify them in advance of 
them worsening.  
For many years, physicians used the subcutaneous route of delivery 
of insulin based on sliding scale16. This has recently seen a reduction and 
newer regimens have entered the scene. Recent studies have shown that 
intravenous insulin infusion is in fact a better alternative, maybe owing to 
the 100 % bioavailability as compared to the erratic absorption of the 
subcutaneous route. Of the intravenous infusion regimens also there are 
many types, one of which is the variable rate glucose insulin type. The 
glucose and the insulin runs separately so that each can be adjusted 
independent of the other24. This also has it’s disadvantage as unnoticed 
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running out of one of the infusions can be catastrophic. IV insulin 
infusion utilises an easy method to maintain blood sugar regulation over a 
broad range of insulin needs.  
The aim is to keep blood glucose levels within a desired scale 
(example., 120 to 180 mg% in the course of the surgical period. In a 
patient with type 1 diabetes, the insulin infusion is started at a rate of 0.5 
to 1 U per hour. In a patient with poor control or in one with type 2 
diabetes, the starting dose is mostly higher, about 2 to 3 U per hour or 
more. The infusion rate is adjusted according to a glucose feedback 
protocol based on hourly glucose readings. 
Another type of insulin infusion is the combined glucose insulin 
regimen or the glucose-insulin-potassium regimen, wherein glucose and 
insulin run together in the same line. It can be used for both insulin 
dependant as well as non insulin dependant diabetic patients 1. The 
advantage of this technique is the safety. There is no risk of one drug 
running out. One of the cons of this method is that it doesn’t allow to 
separately alter the insulin and glucose delivery as may be needed. Every 
time the ratio of insulin to glucose has to be changed a fresh solution has 
to be prepared. But once the variations in sugars reach a minimum, the 
same solution can be used up for the rest of the duration of the 
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procedure13. A new concentration of solution must be prepared if the ratio 
of insulin to glucose requires changing.  
In one intervention trial in patients undergoing cardiac surgery, 
attempting to achieve intraoperative tight glycaemic control (<100mg %) 
did not show improvement in outcomes when compared to good 
glycaemic control (<200mg%). However, in another study by 
Subramanian et al., involving 236 patients undergoing vascular surgery, 
subjects randomized preoperatively to a continuous intravenous insulin 
infusion protocol (goal glucose range 100–150mg%) versus an 
intermittent intravenous bolus protocol (treatment if >150mg%) had a 
lower rate of perioperative heart attack5.  
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Even though the role of subcutaneous insulin in the intraoperative 
period is diminished, it is still used by some for perioperative 
management. Erratic absorption of the subcutaneous dose, which is 
otherwise a normal problem, becomes more unpredictable in the 
perioperative period due to altered tissue perfusion, especially in the 
obese. If for some reason the surgery is unexpectedly extended in time or 
the case is taken up later than planned then the effect of the subcutaneous 
dose may not last as long as needed. However, the approach may be of 
use if the procedure involved is a minor, lasting for a brief duration of 
time.  
In some instances one may find patients who are using continuous 
infusion pumps which deliver the drugs into the subcutaneous tissue. 
Such patients receive insulin which only acts for a short period. During 
surgery is not very difficult to convert the route of administration to 
intravenous route. If the procedure is very brief of if the case is being 
done under local anaesthesia then one may continue with the 
subcutaneous pump instead of changing over to IV insulin16 
In patients with type 2 DM whose control of blood sugar has been 
very good through the years it is enough to just measure the blood sugar 
at least once in every two hours. Insulin needs to be commenced when the 
glucose values reach 180mg% to 200mg%. However, one must keep in 
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mind that blood glucose regulation is capable of deteriorating at any 
instant even in such well managed patients because of surgical. To the 
stress factor, we can add complications like infection, steroidal drugs.  
Glucose, Fluid, And Electrolyte Management 
Most physicians advocate administration of glucose at the rate of 5 
grams per hour in diabetic patients who are going to be treated with 
continuous insulin. The rationale being, the body needs a sustained source 
of glucose as fuel without which catabolism will set in. Fats and protein 
will be broken down in a process called gluconeogenesis after the 
glycogen stores near exhaustion. The more stressful the situation the 
greater the glucose requirement. Also, continuous administration of 
insulin necessitates glucose infusion because insulin itself suppresses 
gluconeogenesis and glycogenolysis.  
There are various concentrations of dextrose containing solutions 
to choose from. The selection of the appropriate one is based upon the 
duration for which one needs to administer and other patient factors. It is 
preferable to use 5%dextrose in a volume of 100 ml for procedures. As 
the procedure length increases one can choose a solution containing a 
higher concentration of glucose so as to restrict the water intake. Other 
concentrations available are 10 %, 20% and 50%. the replacement and 
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maintenance of body fluids during surgery should be done through 
separately infused balanced salt solutions16.  
Changes in concentration of potassium occur more than with other 
ions in the pathophysiology of diabetes mellitus. Insulin causes Potassium 
to transfer into cells. DM complications like hyper glycaemia can result 
in shift of potassium out of cells. The same goes for acidosis occurring in 
DKA, which leads to exchange of the potassium within cells for hydrogen 
ions outside. It therefore obvious that potassium level monitoring is an 
important part of any insulin regimen. However, one must be careful to 
note that serum potassium levels may not give an accurate picture of the 
potassium stores of the body. In DM patients whose renal function tests 
show no abnormality and whose serum potassium levels are within 
normal limits, one should add 10meq/L – 20meq/L of potassium for every 
litre of dextrose containing fluid. The dose can increase if serum 
potassium levels are low. Potassium can be withheld till the values 
normalise for patients with hyperkalaemia.  
Postoperative Management 
In the postoperative period it is common to see subcutaneous 
sliding scale regimens being followed. Many don’t recommend this 
approach because the variability of glycaemic values tend to be high due 
to the disadvantages associated with the route. Such patients are at high 
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risk of ending up in DKA due to persistent hyperglycaemia. It is therefore 
advisable to stay on the safer side by resorting to intravenous insulin 
regimens until the patient is capable of oral intake.  
When food is ready to be started the patient should receive the 
regular dose of insulin subcutaneously prior to food. Meanwhile, the 
intravenous administration can continue till two hours later.  
There might be patients who did not require insulin 
intraoperatively but exhibit the need for it in the period after surgery. The 
subcutaneous route can be used in such cases at a dose of 0.5-0.7 IU/kg 
body weight, which has to be split into insulin of short duration of action 
before each meal or a combination of intermediate acting with short 
acting insulin two times a day before meals or a combination of long 
acting insulin at bedtime and short acting insulin before each meal.  
If the oral intake started is liquid in nature then it is best to 
continue with the IV regimen instead of opting for the subcutaneous 
regimen. Liquid diets have varying levels of sugar which may pose them 
risks of extreme glycaemic values. Liquid diet doesn’t follow a pattern of 
intake and can be consumed at any random time all too frequently, hence 
an intravenous regimen would do these patients more good16. In any case, 
the insulin infusion should carry one until two hours after commencing 
the subcutaneous doses.  
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Previously not much objection existed to allowing mild rises in 
glycaemic levels during surgery. This attitude arose because anaesthetists 
felt safer to permit it in unconscious anaesthetised patients who couldn’t 
communicate their symptoms, thus not risking the overseeing of 
dangerous falls in blood sugar levels. Such thoughts which prevailed then 
are not pardonable anymore as we have very accurate and easy to use 
gadgets at our disposal to conveniently monitor blood sugars. Moreover, 
there is overwhelming evidence in support of strict control of sugars. 
With recent change in attitudes anaesthetists are often aggressive in their 
handling of glucose regulation, as described by a study done in the United 
Kingdoms. But, out of the 172 participants in this survey, twenty two 
percent still wanted to maintain blood glucose above 180mg% in DM 
patients and two percent were in favour of a level of above 234mg%. A 
great proportion of participants managed to regulate sugars in type 1 DM 
patients with insulin infusions, especially for lengthy procedures. A 
staggeringly huge proportion of participants did not think it to be 
imperative, in type 2 DM patients scheduled for smaller surgeries, as they 
believed that omission of glucose containing crystalloid solutions was 
enough to reduce the need for hypoglycaemic agents. Astonishingly, 
nearly twenty percent of experienced anaesthesiologists had a similar 
plan for type2 DM patients who were going through big operations the 
amount of money involved and the difficulties may affect ideas about the 
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rigorousness of glycaemic control and, until recent times, there has not 
been strong proof in favour of tight glucose control regimens for either 
perioperative or ICU care.  
Even to this day there is no general consensus on what is the ideal 
protocol for managing diabetic patients, perhaps because there aren’t 
enough studies done in this. Alberti, Hirsch et al, and Gavin recommend 
that in the perioperative time duration one should maintain glucose levels 
in the range of 10mg% to 200mg% so as to minimise the ill effects 
arising out of not doing so. The incidence of morbidity and mortality 
reduced considerably by doing so1. Van Den Berghe found association of 
decreased death rate with strict insulin treatment in DM patients who 
were in ICU belonging to the surgery department 23. According to 
Jennifer B. Marks, in the article’ Perioperative Management of Diabetes’ 
the target range for blood sugar control can be changed according to the 
demand of the circumstance, if required 14. Generally blood sugar levels 
beyond 200mg% or under 100mg% should be evaded to reduce the 
problems that occur in association with extremes of blood sugar values.  
The type of anaesthesia used has a bearing upon the control of 
blood sugar as pain management differs in regional and general 
anaesthesia so does the stress factor which influences the anti- insulin 
processes within the body. No study supports one type of anaesthesia 
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more than the other when it comes to diabetes mellitus. No evidence 
suggests that one anaesthetic technique or another affects mortality or 
morbidity in diabetic patients. Halter & Pflug showed that spinal 
anaesthesia at the dermatome level of T2–T6caused a lowering in the 
acute counteraction of insulin to blood sugar, while spinal blockade of 
lower levels of a dermatome level of T9–T12 did not cause such 
reduction13.Also, regional techniques have the plus point of letting the 
patient stay awake and minimises the stress of the surgery. Regional 
anaesthesia is also known to reduce blood sugar. The risk of venous 
thromboembolism is also reduced. All is not rosy for the use of central 
neuraxial techniques in DM. Already suffering from autonomic 
neuropathy and cardiovascular ailments, the haemodynamic stability of 
these patients is at a greater compromise in opting for the technique. The 
already damaged nerves are more like to suffer additional damage, which 
may be compounded by poor tissue blood supply.  
Regional anaesthesia poses greater risks in the diabetic patient with 
autonomic neuropathy13.The variations in blood pressure can adversely 
affect the previously affected vital organs and worsen their course of 
deterioration. The altered immunity doesn’t help as the patient is at risk 
of suffering from epidural abscess, or worse, CNS infections easily. In the 
event that the peripheral neuropathy worsens following surgery, this may 
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be blamed upon the anaesthetist as an adverse effect of the regional 
technique6.  
Induction agents may affect the maintenance of blood sugar levels 
intraoperatively. The effect of propofol, however is not well known. 
Thiopentone minimised the potential to prevent the hyperglycaemia 
effects of a high dose of glucose15. Etomidate was found to allow better 
control of sugars by suppressing the synthesis of cortisol.  
Benzodiazepines have two different effect that seem to neutralise 
each other with regard to blood glucose control. They suppress the 
secretion od adrenocorticotrophic hormone and thereby, the formation of 
cortisol in large doses. They also lower stimulation of the sympathetic 
system. While the above described effects should make it easy to regulate 
sugars, there is this opposing effect of increased growth hormone 
secretion. Diabetes related effects are significant for midazolam only 
when used in high doses or continuously as in an infusion6.  
Opioid anaesthetics, when used in large doses are very effective in 
suppressing the sympathetic nervous system. They also have an effect on 
the HPO axis. The result is a relieving degree of haemodynamic as well 
as glycaemic stability, as expected. One must bear in mind at the same 
time that the response to these drugs may be amplified in diabetics and 
should therefore proceed with caution while administering them, giving 
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low doses at a time6. One must consider the renal status of the patient and 
rule out diabetic nephropathy. If present, the dose of morphine requires 
reduction as it’s active metabolite morphine 6 glucuronide is excreted by 
the kidney. The metabolite of fentanyl, norfentanyl, is inactive, though it 
is also excreted by the kidney. Hence, fentanyl doesn’t require dose 
reduction.  
Certain neuro muscular blocking drugs need caution in diabetics. 
Since these patients are more likely to present with hyperkalaemia, the 
use of suxamethonium should follow after confirmation of serum 
Potassium levels to be normal. Suxamethoniumcan increase K+ levels, 
albeit transiently, by 0.5 – 1 meq/L. If starting serum levels of Potassium 
are high then it is better to trade suxamethonium for non depolarising 
blockers. Vecuroniummust be used with caution in patients suffering 
from diabetic nephropathy and the same applies to other drugs depending 
on the kidney for their elimination.  
Halothane, enflurane and isoflurane inhibit the response of insulin 
to blood sugar in a convertible fashion and depends on the dose, in the 
body. The consequence of propofol on the secretion of insulin is 
unknown. DM patients have a diminished capability to empty lipids from 
the circulation. Although this is not likely to be of much importance 
during short anaesthetic procedures when only propofol is utilised for 
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maintenance or as an induction agent, it may have consequences for 
patients who are administered propofol for long periods of sedation in the 
ICU6. 
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SUMMARY 
As already discussed, the primary outcome showed a statistically 
significant efficiency of the Vellore regimen over the IV insulin bolus 
regimen. while the secondary and tertiary outcomes, although in favour of 
the Vellore regimen were not of statistical significance.  
The primary outcome showed a significant difference between the 
two regimen, in favour of the Vellore regimen. The mean blood glucose 
measurement ranged from 156.37 mg/dl at baseline to 152.06 mg/dl at the 
end of 3 hours. Similarly in the Vellore Regimen Group, the mean blood 
glucose measurement ranged from 159.97 mg/dl at baseline to 139.97 
mg/dl at the end of 3 hours. The decreased mean blood glucose 
measurement in Vellore Regimen Group compared to the Insulin Bolus 
Regimen Group is statistically significant as the p value is 0.0367 at 2 
hours and 0.0383 at 3 hours intraoperatively as per unpaired t- test 
indicating a true difference among study groups. 
For the secondary outcome, in comparing the difference between 
the number of patients who were outside the target range at hour 0 and 
hour 3 between both the groups every hour, we find that for the Vellore 
regimen, the percentage dropped from 63% to 0%, while for the insulin 
bolus regimen it decreased from 17 % to 5 %. Although the Vellore 
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Regimen takes the upper hand here, the finding was not found to be 
statistically significant.  
Coming to the tertiary outcome, In patients belonging to Insulin 
Bolus Regimen Group, the mean Blood Glucose Monitoring of Patients 
who had Poor Control at Assessment (FBS≥126, PPBS≥200) ranged from 
211 mg/dl at baseline to 160.60 mg/dl at the end of hour 3. The 
comparison turned out to be insignificant although it was in favour of the 
Vellore regimen. The mean blood glucose measurement varied from 
210.75 mg/dl at baseline to 142.75 mg/dl at the end of hour 3. The 
decreased mean Blood Glucose Monitoring of Patients who had Poor 
Control at Assessment (FBS≥126, PPBS≥200) in Vellore Regimen Group 
compared to the Insulin Bolus Regimen Group is statistically not 
significant as the p value is > 0.05 as per unpaired t- test.  
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CONCLUSION 
Based on all the above findings, I come to the conclusion that the 
Vellore regimen, which is a type of continuous insulin infusion regimen 
is more convenient as well as superior to the intermittent insulin bolus 
regimen in terms of both efficiency and safety. 
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ANNEXURES 
PROFORMA 
NAME:  
AGE:  
SEX:  
WEIGHT  
DIAGNOSIS: 
SURGICAL PROCEDURE DONE: 
PRE OP ASSESSMENT: 
HISTORY: Any Co-morbid illness diabetes mellitus, IHD, Bronchial asthma, 
COPD, Pulmonary tuberculosis etc. 
EXAMINATION: 
General examination 
Pulse -  BP -   Respiratory Rate -  temperature -  SaO2- 
 
Respiratory system 
Cardiovascular system  
Central nervous system 
Gastrointestinal system 
Local examination 
INVESTIGATIONS 
Hb/PCV, CBC, RFT, LFT, RBS, FBS, HbA1c 
 
REGIMEN 
S.NO NAME AGE SEX GA/RA FFBS PPBS BS0 INS0 BS1 INS1 BS2 INS2 BS3 INS3 
               
               
               
               
               
               
               
               
               
 
ABBRIEVATIONS 
GA/RA General Anaesthesia / Regional Anaesthesia 
FBS Fasting Blood Sugar 
PPBS Post Prandial Blood Sugar 
BS0 Blood Sugar at hour 0 
INS0 Insulin Dose at hour 0  
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INFORMATION TO PARTICIPANTS 
Investigator: Dr.GLADWIN. J. FERNANDES 
Name of the Participant  
Title: “A PROSPECTIVE RANDOMISED STUDY 
COMPARING DIFFERENT APPROACHES TO 
INTRAOPERATIVE MANAGEMENTOF DIABETES 
MELLITUS– THE VELLORE REGIMEN VS 
INTERMITTENT IV BOLUS REGIMEN” 
 
You are invited to take part in this research study. We have got approval from 
the IEC. Your are asked to participate because you satisfy the eligibility criteria.  
What is the Purpose of the Research: 
We want to compare different intraoperative glucose control regimen for 
efficacy. 
The Study Design: 
Patients in the study will be divided into two groups, each group consisting of 
35 patients.  
Group A – patients for The Vellore Regimen Group B – Patients for the 
Intermittent IV Bolus Regimen.  
Patients will be evaluated clinically and investigated  
Blood glucose readings will be taken at every hour intraoperatively and 
intervention relevant to the group will be administered 
Benefits  
The study will help to decide on a convenient and effective plan for 
intraoperative blood glucose control 
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Discomforts and risks 
The study poses hardly any risk as the regimens have been in use for a long 
time and any shift of blood glucose to the extremes will be appropriately dealt with. 
Patients who don’t want to be part of study may withdraw as per their wish. 
Time : 
Date : 
Place : 
Signature / Thumb Impression of Patient 
Patient Name: 
Signature of the Investigator : ____________________________ 
Name of the Investigator : ____________________________ 
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PATIENT CONSENT FORM 
Study Title: “A PROSPECTIVE RANDOMISED STUDY COMPARING 
DIFFERENT APPROACHES TO INTRAOPERATIVE 
MANAGEMENT OF DIABETES MELLITUS– THE VELLORE 
REGIMEN VS INTERMITTENT IV BOLUS REGIMEN” 
 
Study Centre: INSTITUTE OF ANAESTHESIOLOGY AND CRITICAL CARE, 
RAJIV GANDHI GOVT. GENERAL HOSPITAL, MADRAS 
MEDICAL COLLEGE, CHENNAI 600003.  
 
Participant Name:   Age:  Sex:  I.P.No: 
 
I confirm that I have understood the purpose of procedure for the above study. 
I have had the opportunity to ask questions and all my questions and doubts have been 
answered to my satisfaction. 
 I understand that my participation in the study is voluntary and that I am free 
to withdraw at anytime without giving any reason. 
 
 I understand that the investigator, regulatory authorities and the ethics 
committee will not need my permission to look at my health records both in respect to 
current study and any further research that may be conducted in relation to it, even if I 
withdraw from the study. I understand that my identity will not be revealed in any 
information released to third parties or published, unless as required under the law. I 
agree not to restrict the use of any data or results that arise from the study. 
 
Time:  
 
Date:  
Place:  
 
 
Signature of the investigator:   Signature/thumb impression of patient 
 
Name of the investigator:   Patient name  
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S.NO NAME AGE SEX GA/RA FBS PPBS BS0 INS0 BS1 INS1 BS2 INS2 BS3 INS3
1 JAYACHANDRAN 52 M GA 110 144 122 0 IU 130 0 IU 110 0 IU 130 0 IU
2 ABHISHEK 56 M RA 108 133 127 0 IU 133 0 IU 138 0 IU 154 2 IU
3 ABDUL 42 M RA 126 200 200 5 IU 183 4 IU 174 3 IU 156 2 IU
4 NARAYANAN 60 M GA 106 148 108 0 IU 152 2 U 163 5 IU 124 0 IU
5 GOPAL 55 M RA 110 150 112 0 IU 128 0 IU 188 8 U 167 5 IU
6 GOPINATH 57 M RA 112 149 156 2 IU 118 0 IU 120 0 IU 157 2 IU
7 SHIVASHANKAR 59 M GA 128 189 210 5 IU 229 12 IU 226 12 IU 130 0 IU
8 ASMIT 46 M RA 116 155 188 4 IU 167 3 IU 134 0 IU 176 5 IU
9 POOJA 50 F RA 100 132 110 0 IU 170 5 IU 157 2 IU 156 4 IU
10 RUDRAKSHA 43 M RA 102 130 173 3 IU 156 2 IU 166 5 IU 124 0 IU
11 SENTHIL 51 M RA 113 128 160 2 IU 112 0 IU 170 5 IU 112 0 IU
12 AKASH 40 M RA 110 133 146 2 IU 200 9 IU 150 4 IU 158 6 IU
13 TEJAS 55 M RA 122 190 200 5 IU 190 4 IU 122 0 IU 140 0 IU
14 VINITA 56 F RA 114 135 166 3 IU 130 0 IU 110 0 IU 112 0 IU
15 PUNEET 56 M GA 117 139 157 2 IU 150 2 IU 174 5 IU 156 6 IU
16 DHYANESHWARAN 59 M RA 120 140 145 2 IU 103 0 IU 159 4 IU 188 12 IU
17 DHANAM 53 F RA 130 210 222 6 IU 228 12 IU 230 18 IU 227 18 IU
18 ADITI 48 M GA 118 150 168 3 IU 140 0 IU 188 8 IU 240 19 IU
19 RAMGOPAL 54 M RA 119 172 134 0 IU 157 4 IU 122 0 IU 117 0 IU
20 ANAND 54 M GA 127 178 220 6 IU 159 2 IU 100 0 IU 124 0 IU
21 BHARATH 42 M RA 125 157 180 4 IU 99 0 IU 160 4 IU 154 4 IU
22 YUVARAJAN 53 M GA 110 120 150 2 IU 129 0 IU 172 5 IU 166 5 IU
23 SHAKTIVEL 44 M RA 111 133 103 0 IU 160 4 IU 155 4 IU 170 7 IU
24 POOVARASAN 58 M GA 114 134 155 2 IU 185 8 IU 140 0 IU 128 0 IU
25 SEKAR 59 M RA 109 123 112 0 IU 130 0 IU 120 0 IU 133 0 IU
26 KATHIR 53 M RA 106 118 129 0 IU 144 4 IU 58 0 IU 151 4 IU
27 SALIM 47 M RA 117 160 188 4 IU 240 13 IU 166 5 IU 174  IU
28 SHIVAKARTHIK 56 M GA 127 206 203 5 IU 180 4 IU 154 4 IU 166 7 IU
29 VINOD 58 M GA 109 128 151 2 IU 198 9 IU 158 4 IU 168 7 IU
30 JAGADISHWARAN 49 M GA 108 130 130 0 IU 144 4 IU 127 0 IU 118 0 IU
31 ANBARASAN 52 M RA 107 136 135 0 IU 148 4 IU 130 0 IU 126 0 IU
32 SUNIL 50 M RA 104 128 111 0 IU 155 4 IU 160 6 IU 117 0 IU
33 SURESH 51 M RA 113 140 158 2 IU 226 12 IU 162 5 IU 159 4 IU
34 DEEPAK 51 M RA 119 142 190 4 IU 160 4 IU 150 2 IU 190 8 IU
35 ANKIT 47 M RA 112 138 154 2 IU 100 0 IU 120  0 IU 144 6 IU
INSULIN BOLUS REGIMEN
MASTER CHART
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S.NO                  Name Age Sex GA/RA FBS PPBS BS0 INS0 BS1 INS1 BS2 INS2 BS3 INS3
1 PALANI 50 M RA 109 146 108 1 IU 110 1 U 128 1 IU 124 1 IU
2 RAGHU 50 M GA 128 205 220 3 IU 200 2 IU 146 1 IU 130 1 IU
3 BRAHADISHWARAN 55 M RA 110 150 126 1 IU 124 1 IU 159 2 IU 142 1 IU
4 SARAVANAN 44 M RA 116 155 156 2 IU 160 2 IU 155 2 IU 155 2 IU
5 ELMALAI 58 M GA 100 138 134 1 IU 128 1 IU 137 1 IU 161 2 IU
6 RAJENDRAN 59 M RA 112 148 157 2 IU 119 1 IU 146 1 IU 122 1 IU
7 KARTHIKEYAN 59 M RA 115 142 180 2 IU 156 2 U 162 2 IU 118 1 IU
8 JAGADISH 44 M RA 124 170 200 2 IU 172 2 IU 161 2 IU 146 1 IU
9 VANAJA 42 F RA 122 160 209 3 IU 110 1 IU 149 1 IU 139 1 IU
10 PRABHAKARAN 44 M GA 105 138 112 1 IU 118 1 IU 138 1 IU 170 2 IU
11 PRADEEP 38 M RA 118 190 144 1 IU 168 2 IU 186 2 IU 163 2 IU
12 SATHISH 56 M RA 130 210 202 3 IU 228 3 IU 232 3 IU 154 2 IU
13 RAJANANDAN 55 M GA 102 130 112 1 IU 154 2 U 150 1 IU 129 1 IU
14 RAM 40 M RA 120 196 133 1 IU 140 1 IU 149 1 IU 144 1 U
15 RAMANIKANT 41 M RA 109 145 114 1 IU 122 1 IU 130 1 IU 138 1 IU
16 SAKIR AHAMAD 52 M RA 125 189 167 2 IU 135 1 U 160 2 IU 177 2 IU
17 MANI 47 M GA 110 150 118 1 IU 186 2 IU 158 2 IU 152 2 U
18 KULANTHAIVELU 51 M GA 113 155 170 2 IU 159 2 IU 120 1 IU 126 1 IU
19 GEETA 54 F RA 125 170 210 3 IU 120 1 U 140 1 IU 133 1 IU
20 LAXMAN 45 M GA 117 160 136 1 IU 112 1 IU 151 2 IU 122 1 IU
21 JOHN 54 M RA 102 130 152 2 IU 160 2 U 175 2 IU 158 2 IU
22 PRAKASH 58 M GA 109 140 150 1 IU 159 2 IU 110 1 IU 110 1 IU
23 MOHAMMAD 44 M RA 110 142 190 2 IU 110 1 IU 133 1 IU 108 1 IU
24 SURENDRA 59 M RA 113 149 140 1 IU 102 1 IU 154 2 IU 140 1 IU
25 VIPIN 53 M RA 112 150 183 2 IU 160 2 IU 164 2 IU 166 2 IU
26 BHASKAR 53 M GA 127 190 216 3 IU 230 3 IU 180 2 IU 122 1 IU
27 VIJAY 52 M RA 118 180 190 2 U 200 2 IU 176 2 IU 138 1 IU
28 JAYAM 59 M RA 124 186 207 3 IU 166 2 IU 130 1 IU 110 1 IU
29 RAVI 57 M RA 117 159 154 2 IU 104 1 IU 122 1 IU 159 2 IU
30 RAMANATHAN 48 M RA 118 160 132 1 IU 112 1 U 126 1 IU 122 1 IU
31 BALASUBRAMANYAM 55 M GA 104 144 107 1 IU 170 2 IU 128 1 IU 136 1 IU
32 RAGUDEEPAN 55 M RA 123 188 175 2 IU 180 2 IU 154 2 IU 136 1 IU
33 AMIT 58 M RA 129 190 205 3 U 150 1 IU 160 2 IU 165 2 IU
34 ZAKHIR 49 M RA 120 150 150 1 IU 108 1 IU 136 1 IU 144 1 IU
35 AHMED 52 M RA 117 155 140 1 IU 109 1 IU 129 1 IU 140 1 IU
VELLORE REGIMEN
